본문으로 건너뛰기
← 뒤로

Retraction Statement.

1/5 보강
Oncology research and treatment 2026 Vol.49(4) p. 236
Retraction 확인
출처
📝 환자 설명용 한 줄

The authors' accepted manuscript "TACE Combined with Hepatic Arterial Infusion of Nivolumab for Inhibiting Tumor Angiogenesis in Hepatocellular Carcinoma" [Oncol Res Treat.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA (2026). Retraction Statement.. Oncology research and treatment, 49(4), 236. https://doi.org/10.1159/000550500
MLA . "Retraction Statement.." Oncology research and treatment, vol. 49, no. 4, 2026, pp. 236.
PMID 41642762
DOI 10.1159/000550500

Abstract

The authors' accepted manuscript "TACE Combined with Hepatic Arterial Infusion of Nivolumab for Inhibiting Tumor Angiogenesis in Hepatocellular Carcinoma" [Oncol Res Treat. 2025; https://doi.org/10.1159/000549516] by Sujing Zhang, Zheng Zheng, Changwang Zhang, Xueqian Liu, Xinlei Shi, and Wenhua Ma has been retracted by the Publisher and the Editor on behalf of the authors.After peer review, the accepted, unedited manuscript was published online as Early View. Subsequently, the authors requested to withdraw the manuscript from the journal. As the article is not approved by the authors for publication, we are retracting the Early View accepted, unedited manuscript.